☰

Barry T. Rouse - Publications

Affiliations: 
The University of Tennessee, Knoxville, TN, United States 
Area:
Immunology, Pathology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

300/406 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2025 Mielcarska MB, Rouse BT. Viruses and the Brain-A Relationship Prone to Trouble. Viruses. 17. PMID 40006958 DOI: 10.3390/v17020203  0.305
2024 Antony F, Kinha D, Nowińska A, Rouse BT, Suryawanshi A. The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis. Clinical Microbiology Reviews. e0000624. PMID 39078136 DOI: 10.1128/cmr.00006-24  0.327
2024 Berber E, Mulik S, Rouse BT. Meeting the Challenge of Controlling Viral Immunopathology. International Journal of Molecular Sciences. 25. PMID 38612744 DOI: 10.3390/ijms25073935  0.336
2024 Sharma S, Kumar N, Rouse BT, Sharma K, Chaubey KK, Singh S, Kumar P, Kumar P. The role, relevance and management of immune exhaustion in bovine infectious diseases. Heliyon. 10: e28663. PMID 38596123 DOI: 10.1016/j.heliyon.2024.e28663  0.313
2023 Mulik S, Berber E, Sehrawat S, Rouse BT. Controlling viral inflammatory lesions by rebalancing immune response patterns. Frontiers in Immunology. 14: 1257192. PMID 37671156 DOI: 10.3389/fimmu.2023.1257192  0.337
2023 Berber E, Rouse BT. Controlling viral inflammatory lesions by inhibiting fatty acid metabolism. Microbes and Infection. 105141. PMID 37085045 DOI: 10.1016/j.micinf.2023.105141  0.384
2023 Ren J, Antony F, Rouse BT, Suryawanshi A. Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis. Pathogens (Basel, Switzerland). 12. PMID 36986359 DOI: 10.3390/pathogens12030437  0.371
2022 Berber E, Rouse BT. Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin. Journal of Virology. e0068822. PMID 35862706 DOI: 10.1128/jvi.00688-22  0.315
2021 Sumbria D, Berber E, Miller L, Rouse BT. Modulating glutamine metabolism to control viral immuno-inflammatory lesions. Cellular Immunology. 370: 104450. PMID 34678554 DOI: 10.1016/j.cellimm.2021.104450  0.414
2021 Berber E, Sumbria D, Newkirk KM, Rouse BT. Inhibiting Glucose Metabolism Results in Herpes Simplex Encephalitis. Journal of Immunology (Baltimore, Md. : 1950). 207: 1824-1835. PMID 34470854 DOI: 10.4049/jimmunol.2100453  0.402
2020 Sumbria D, Berber E, Rouse BT. Supplementing the diet with sodium propionate suppresses the severity of viral immuno-inflammatory lesions. Journal of Virology. PMID 33208449 DOI: 10.1128/JVI.02056-20  0.391
2020 Sehrawat S, Rouse BT. Opinion: Does the hygiene hypothesis apply to COVID-19 susceptibility? Microbes and Infection. PMID 32653475 DOI: 10.1016/J.Micinf.2020.07.002  0.375
2020 Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT. Host-Directed Antiviral Therapy. Clinical Microbiology Reviews. 33. PMID 32404434 DOI: 10.1128/Cmr.00168-19  0.351
2019 Sumbria D, Berber E, Rouse BT. Factors Affecting the Tissue Damaging Consequences of Viral Infections. Frontiers in Microbiology. 10: 2314. PMID 31636623 DOI: 10.3389/Fmicb.2019.02314  0.405
2019 Rajasagi NK, Rouse BT. The Role of T Cells in Herpes Stromal Keratitis. Frontiers in Immunology. 10: 512. PMID 30941142 DOI: 10.3389/Fimmu.2019.00512  0.506
2019 Machala EA, McSharry BP, Rouse BT, Abendroth A, Slobedman B. Gal power: the diverse roles of galectins in regulating viral infections. The Journal of General Virology. PMID 30648945 DOI: 10.1099/Jgv.0.001208  0.463
2018 Varanasi SK, Rajasagi NK, Jaggi U, Rouse BT. Role of IL-18 induced Amphiregulin expression on virus induced ocular lesions. Mucosal Immunology. PMID 30087443 DOI: 10.1038/S41385-018-0058-8  0.408
2018 Kumar N, Sharma S, Barua S, Tripathi BN, Rouse BT. Virological and Immunological Outcomes of Coinfections. Clinical Microbiology Reviews. 31. PMID 29976554 DOI: 10.1128/Cmr.00111-17  0.458
2018 Sehrawat S, Kumar D, Rouse BT. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases? Frontiers in Cellular and Infection Microbiology. 8: 177. PMID 29888215 DOI: 10.3389/Fcimb.2018.00177  0.386
2018 Jaggi U, Varanasi SK, Bhela S, Rouse BT. On the Role of Retinoic Acid in virus induced Inflammatory Response in Cornea. Microbes and Infection. PMID 29842984 DOI: 10.1016/J.Micinf.2018.04.007  0.435
2018 Varanasi SK, Jaggi U, Hay N, Rouse BT. Hexokinase II may be dispensable for CD4 T cell responses against a virus infection. Plos One. 13: e0191533. PMID 29352298 DOI: 10.1371/Journal.Pone.0191533  0.519
2018 Rajasagi NK, Rouse BT. Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy. Microbes and Infection. PMID 29329934 DOI: 10.1016/J.Micinf.2017.12.014  0.367
2017 Bhela S, Rouse BT. Are miRNAs critical determinants in Herpes Simplex Virus pathogenesis? Microbes and Infection. PMID 29287990 DOI: 10.1016/J.Micinf.2017.12.007  0.318
2017 Varanasi SK, Rouse BT. How host metabolism impacts on virus pathogenesis. Current Opinion in Virology. 28: 37-42. PMID 29156318 DOI: 10.1016/J.Coviro.2017.11.003  0.387
2017 Bhela S, Rouse BT. miR-31: a key player in CD8 T-cell exhaustion. Cellular & Molecular Immunology. PMID 28890544 DOI: 10.1038/Cmi.2017.89  0.331
2017 Varanasi SK, Donohoe D, Jaggi U, Rouse BT. Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects. Journal of Immunology (Baltimore, Md. : 1950). PMID 28768727 DOI: 10.4049/Jimmunol.1700472  0.456
2017 Bhela S, Varanasi SK, Jaggi U, Sloan SS, Rajasagi NK, Rouse BT. The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions. Journal of Immunology (Baltimore, Md. : 1950). PMID 28710254 DOI: 10.4049/Jimmunol.1700520  0.502
2017 Rajasagi NK, Bhela S, Varanasi SK, Rouse BT. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. Journal of Leukocyte Biology. PMID 28584076 DOI: 10.1189/Jlb.3Hi1216-511Rr  0.507
2017 Sehrawat S, Rouse BT. Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals. Frontiers in Immunology. 8: 341. PMID 28421070 DOI: 10.3389/Fimmu.2017.00341  0.493
2017 Varanasi SK, Reddy PB, Bhela S, Jaggi U, Gimenez F, Rouse BT. Azacytidine treatment inhibits the progression of Herpes Stromal Keratitis by enhancing regulatory T cell function. Journal of Virology. PMID 28100624 DOI: 10.1128/Jvi.02367-16  0.547
2016 Rajasagi NK, Rouse BT. IL-2 complex treatment amplifies CD8(+) T cell mediated immunity following herpes simplex virus-1 infection. Microbes and Infection. PMID 27866863 DOI: 10.1016/J.Micinf.2016.10.010  0.525
2016 Rouse BT, Mueller SN. Some vexations that challenge viral immunology. F1000research. 5. PMID 27303640 DOI: 10.12688/F1000Research.8391.1  0.403
2015 Gimenez F, Mulik S, Veiga-Parga T, Bhela S, Rouse BT. Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis. Plos One. 10: e0141925. PMID 26720197 DOI: 10.1371/Journal.Pone.0141925  0.409
2015 Gimenez F, Bhela S, Dogra P, Harvey L, Varanasi SK, Jaggi U, Rouse BT. The inflammasome NLRP3 plays a protective role against a viral immunopathological lesion. Journal of Leukocyte Biology. PMID 26516184 DOI: 10.1189/Jlb.3Hi0715-321R  0.515
2015 Bhela S, Mulik S, Gimenez F, Reddy PB, Richardson RL, Varanasi SK, Jaggi U, Xu J, Lu PY, Rouse BT. Role of miR-155 in the pathogenesis of herpetic stromal keratitis. The American Journal of Pathology. 185: 1073-84. PMID 25700796 DOI: 10.1016/J.Ajpath.2014.12.021  0.437
2014 Mayer CT, Lahl K, Milanez-Almeida P, Watts D, Dittmer U, Fyhrquist N, Huehn J, Kopf M, Kretschmer K, Rouse B, Sparwasser T. Advantages of Foxp3(+) regulatory T cell depletion using DEREG mice. Immunity, Inflammation and Disease. 2: 162-5. PMID 25505550 DOI: 10.1002/Iid3.33  0.453
2014 Sharma S, Rajasagi NK, Veiga-Parga T, Rouse BT. Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection. Microbes and Infection / Institut Pasteur. 16: 648-60. PMID 24956596 DOI: 10.1016/J.Micinf.2014.06.005  0.552
2014 Reddy PB, Sehrawat S, Suryawanshi A, Rajasagi NK, Khatri M, Rouse BT. An approach to control relapse of inflammatory lesions after discontinuation of primary therapy. Plos One. 9: e98051. PMID 24846129 DOI: 10.1371/Journal.Pone.0098051  0.444
2014 Bhela S, Mulik S, Reddy PB, Richardson RL, Gimenez F, Rajasagi NK, Veiga-Parga T, Osmand AP, Rouse BT. Critical role of microRNA-155 in herpes simplex encephalitis. Journal of Immunology (Baltimore, Md. : 1950). 192: 2734-43. PMID 24516198 DOI: 10.4049/Jimmunol.1302326  0.439
2013 Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunological Reviews. 255: 182-96. PMID 23947355 DOI: 10.1111/Imr.12085  0.537
2013 Rajasagi NK, Reddy PB, Mulik S, Gjorstrup P, Rouse BT. Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Investigative Ophthalmology & Visual Science. 54: 6269-79. PMID 23942967 DOI: 10.1167/Iovs.13-12152  0.483
2013 Veiga-Parga T, Giménez F, Mulik S, Chiang EY, Grogan JL, Rouse BT. Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. Microbes and Infection / Institut Pasteur. 15: 677-87. PMID 23850656 DOI: 10.1016/J.Micinf.2013.07.001  0.431
2013 Giménez F, Suryawanshi A, Rouse BT. Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Progress in Retinal and Eye Research. 33: 1-9. PMID 22892644 DOI: 10.1016/J.Preteyeres.2012.07.002  0.422
2012 Veiga-Parga T, Suryawanshi A, Mulik S, Giménez F, Sharma S, Sparwasser T, Rouse BT. On the role of regulatory T cells during viral-induced inflammatory lesions. Journal of Immunology (Baltimore, Md. : 1950). 189: 5924-33. PMID 23129753 DOI: 10.4049/Jimmunol.1202322  0.517
2012 J Reddy PB, Schreiber TH, Rajasagi NK, Suryawanshi A, Mulik S, Veiga-Parga T, Niki T, Hirashima M, Podack ER, Rouse BT. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. Journal of Virology. 86: 10606-20. PMID 22811539 DOI: 10.1128/Jvi.01391-12  0.524
2012 Mulik S, Xu J, Reddy PB, Rajasagi NK, Gimenez F, Sharma S, Lu PY, Rouse BT. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. The American Journal of Pathology. 181: 525-34. PMID 22659469 DOI: 10.1016/J.Ajpath.2012.04.014  0.383
2012 Rajasagi NK, Suryawanshi A, Sehrawat S, Reddy PB, Mulik S, Hirashima M, Rouse BT. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. Journal of Immunology (Baltimore, Md. : 1950). 188: 4631-43. PMID 22467659 DOI: 10.4049/Jimmunol.1103063  0.511
2012 Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK, Rouse BT. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 3434-46. PMID 22379030 DOI: 10.4049/Jimmunol.1102602  0.345
2011 Veiga-Parga T, Suryawanshi A, Rouse BT. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. Plos Pathogens. 7: e1002427. PMID 22174686 DOI: 10.1371/Journal.Ppat.1002427  0.501
2011 Sharma S, Sundararajan A, Suryawanshi A, Kumar N, Veiga-Parga T, Kuchroo VK, Thomas PG, Sangster MY, Rouse BT. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proceedings of the National Academy of Sciences of the United States of America. 108: 19001-6. PMID 22052881 DOI: 10.1073/Pnas.1107087108  0.54
2011 Reddy PB, Sehrawat S, Suryawanshi A, Rajasagi NK, Mulik S, Hirashima M, Rouse BT. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. Journal of Immunology (Baltimore, Md. : 1950). 187: 5745-55. PMID 22021615 DOI: 10.4049/Jimmunol.1102105  0.51
2011 Sehrawat S, Rouse BT. Tregs and infections: on the potential value of modifying their function. Journal of Leukocyte Biology. 90: 1079-87. PMID 21914856 DOI: 10.1189/Jlb.0611271  0.495
2011 Suryawanshi A, Veiga-Parga T, Rajasagi NK, Reddy PB, Sehrawat S, Sharma S, Rouse BT. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. Journal of Immunology (Baltimore, Md. : 1950). 187: 1919-30. PMID 21765013 DOI: 10.4049/Jimmunol.1100736  0.48
2011 Mulik S, Sharma S, Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK, Rouse BT. Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis. Journal of Immunology (Baltimore, Md. : 1950). 186: 7195-204. PMID 21572022 DOI: 10.4049/Jimmunol.1100014  0.341
2011 Sharma S, Mulik S, Kumar N, Suryawanshi A, Rouse BT. An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. Journal of Virology. 85: 5995-6007. PMID 21471229 DOI: 10.1128/Jvi.00034-11  0.439
2011 Suryawanshi A, Mulik S, Sharma S, Reddy PB, Sehrawat S, Rouse BT. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. Journal of Immunology (Baltimore, Md. : 1950). 186: 3653-65. PMID 21325621 DOI: 10.4049/Jimmunol.1003239  0.369
2011 Mott KR, Gate D, Zandian M, Allen SJ, Rajasagi NK, van Rooijen N, Chen S, Arditi M, Rouse BT, Flavell RA, Town T, Ghiasi H. Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs. Investigative Ophthalmology & Visual Science. 52: 2321-33. PMID 21220560 DOI: 10.1167/Iovs.10-6536  0.501
2011 Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. Journal of Immunology (Baltimore, Md. : 1950). 186: 1735-46. PMID 21187448 DOI: 10.4049/Jimmunol.1003456  0.518
2010 Rouse BT, Lukacher AE. Some unmet challenges in the immunology of viral infections. Discovery Medicine. 10: 363-70. PMID 21034678  0.323
2010 Araki K, Gangappa S, Dillehay DL, Rouse BT, Larsen CP, Ahmed R. Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. The Journal of Experimental Medicine. 207: 2355-67. PMID 20921283 DOI: 10.1084/Jem.20100124  0.517
2010 Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nature Reviews. Immunology. 10: 514-26. PMID 20577268 DOI: 10.1038/Nri2802  0.426
2010 Sehrawat S, Reddy PB, Rajasagi N, Suryawanshi A, Hirashima M, Rouse BT. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. Plos Pathogens. 6: e1000882. PMID 20463811 DOI: 10.1371/Journal.Ppat.1000882  0.532
2010 Campbell IL, Manders P, Lim S, Terry RL, Getts MT, Getts DR, King NJC, Hofer MJ, Araki K, Gangappa S, Rouse BT, Larsen CP, Ahmed R, Shimizu VS, Diego RPd, et al. Immunity to virus infection (excluding retroviruses) 1 (WS-025a) Chairpersons: Yusuke Yanagi, Nicholas King International Immunology. 22. DOI: 10.1093/Intimm/Dxq181  0.403
2009 Sehrawat S, Suryawanshi A, Hirashima M, Rouse BT. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. Journal of Immunology (Baltimore, Md. : 1950). 182: 3191-201. PMID 19234217 DOI: 10.4049/Jimmunol.0803673  0.491
2009 Rodrigues L, Nandakumar S, Bonorino C, Rouse BT, Kumaraguru U. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Molecular Immunology. 46: 1494-504. PMID 19233474 DOI: 10.1016/J.Molimm.2008.12.033  0.475
2009 Sarangi PP, Woo SR, Rouse BT. Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction. Clinical Immunology (Orlando, Fla.). 131: 31-40. PMID 19070547 DOI: 10.1016/J.Clim.2008.10.008  0.497
2008 Nandakumar S, Woolard SN, Yuan D, Rouse BT, Kumaraguru U. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. Journal of Virology. 82: 10820-31. PMID 18715907 DOI: 10.1128/Jvi.00365-08  0.521
2008 Sarangi PP, Kim B, Rouse BT. Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis. Investigative Ophthalmology & Visual Science. 49: 5425-33. PMID 18689698 DOI: 10.1167/Iovs.07-1638  0.337
2008 Suvas S, Kim B, Rouse BT. Homeostatic expansion of CD4(+) T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology. Microbes and Infection / Institut Pasteur. 10: 1192-200. PMID 18657630 DOI: 10.1016/J.Micinf.2008.06.012  0.517
2008 Sehrawat S, Rouse BT. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators. Journal of Immunology (Baltimore, Md. : 1950). 180: 7636-47. PMID 18490766 DOI: 10.4049/Jimmunol.180.11.7636  0.494
2008 Sehrawat S, Suvas S, Sarangi PP, Suryawanshi A, Rouse BT. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. Journal of Virology. 82: 6838-51. PMID 18480441 DOI: 10.1128/Jvi.00697-08  0.511
2008 Sarangi PP, Sehrawat S, Suvas S, Rouse BT. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. Journal of Immunology (Baltimore, Md. : 1950). 180: 6297-306. PMID 18424753 DOI: 10.4049/Jimmunol.180.9.6297  0.464
2008 Pack CD, Gierynska M, Rouse BT. An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus. Human Vaccines. 4: 360-4. PMID 18382144 DOI: 10.4161/Hv.4.5.5978  0.468
2008 Kim B, Sarangi PP, Azkur AK, Kaistha SD, Rouse BT. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes and Infection / Institut Pasteur. 10: 302-12. PMID 18325811 DOI: 10.1016/J.Micinf.2007.12.007  0.486
2007 Rouse BT, Suvas S. Regulatory T cells and immunity to pathogens. Expert Opinion On Biological Therapy. 7: 1301-9. PMID 17727321 DOI: 10.1517/14712598.7.9.1301  0.464
2007 Sarangi PP, Kim B, Kurt-Jones E, Rouse BT. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. Journal of Virology. 81: 11128-38. PMID 17686871 DOI: 10.1128/Jvi.01008-07  0.484
2007 Rouse BT. Regulatory T cells in health and disease Journal of Internal Medicine. 262: 78-95. PMID 17598816 DOI: 10.1111/j.1365-2796.2007.01836.x  0.301
2007 Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 65-75. PMID 17266445 DOI: 10.1089/Jir.2007.0077  0.794
2007 Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, Hanson HL, Steinberg JP, Masopust D, Wherry EJ, Altman JD, Rouse BT, Freeman GJ, Ahmed R, Grakoui A. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. Journal of Virology. 81: 2545-53. PMID 17182670 DOI: 10.1128/Jvi.02021-06  0.388
2007 Vanitha DJ, Joo HM, Rouse BT, Sangster MY. Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection. Virology. 360: 136-42. PMID 17113122 DOI: 10.1016/J.Virol.2006.10.006  0.426
2007 Rouse BT, Sehrawat S. Regulatory T Cells and Infectious Disease Immune Network. 7: 167. DOI: 10.4110/In.2007.7.4.167  0.473
2006 Kim B, Lee S, Kaistha SD, Rouse BT. Application of FGF-2 to modulate herpetic stromal keratitis. Current Eye Research. 31: 1021-8. PMID 17169840 DOI: 10.1080/02713680601038824  0.413
2006 Kim B, Sarangi PP, Lee Y, Deshpande Kaistha S, Lee S, Rouse BT. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. Journal of Leukocyte Biology. 80: 1405-15. PMID 16997857 DOI: 10.1189/Jlb.0406295  0.633
2006 Kim B, Suvas S, Sarangi PP, Lee S, Reisfeld RA, Rouse BT. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. Journal of Immunology (Baltimore, Md. : 1950). 177: 4122-31. PMID 16951377 DOI: 10.4049/Jimmunol.177.6.4122  0.457
2006 Rouse BT, Sarangi PP, Suvas S. Regulatory T cells in virus infections. Immunological Reviews. 212: 272-86. PMID 16903920 DOI: 10.1111/J.0105-2896.2006.00412.X  0.531
2006 Li X, Vanitha DJ, Joo HM, He Y, Rouse BT, Sangster MY. A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis. Journal of Immunological Methods. 313: 110-8. PMID 16730022 DOI: 10.1016/J.Jim.2006.03.016  0.448
2006 Kalia V, Sarkar S, Gourley TS, Rouse BT, Ahmed R. Differentiation of memory B and T cells. Current Opinion in Immunology. 18: 255-64. PMID 16632337 DOI: 10.1016/J.Coi.2006.03.020  0.323
2006 Suvas S, Rouse BT. Treg control of antimicrobial T cell responses. Current Opinion in Immunology. 18: 344-8. PMID 16616481 DOI: 10.1016/J.Coi.2006.03.005  0.458
2006 Rouse BT, Masopust D. Waking up T cells to counteract chronic infections. Trends in Immunology. 27: 205-7. PMID 16584922 DOI: 10.1016/J.It.2006.03.008  0.459
2006 Rouse BT, Kaistha SD. A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 810-7. PMID 16477558 DOI: 10.1086/500141  0.336
2006 Suvas S, Azkur AK, Rouse BT. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. Journal of Immunology (Baltimore, Md. : 1950). 176: 1703-11. PMID 16424200 DOI: 10.4049/Jimmunol.176.3.1703  0.471
2006 Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Experimental Eye Research. 82: 46-54. PMID 16009363 DOI: 10.1016/J.Exer.2005.05.001  0.77
2005 Kim B, Deshpande Kaistha S, Rouse BT. Viruses and autoimmunity. Autoimmunity. 38: 559-65. PMID 16390809 DOI: 10.1080/08916930500356583  0.392
2005 Suvas S, Rouse BT. Regulation of microbial immunity: the suppressor cell renaissance. Viral Immunology. 18: 411-8. PMID 16212520 DOI: 10.1089/Vim.2005.18.411  0.448
2005 Suvas S, Kim B, Sarangi PP, Tone M, Waldmann H, Rouse BT. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. Journal of Virology. 79: 11935-42. PMID 16140769 DOI: 10.1128/Jvi.79.18.11935-11942.2005  0.506
2005 Kumaraguru U, Banerjee K, Rouse BT. In vivo rescue of defective memory CD8+ T cells by cognate helper T cells. Journal of Leukocyte Biology. 78: 879-87. PMID 16081600 DOI: 10.1189/Jlb.0105007  0.705
2005 Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, Johnson DC. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proceedings of the National Academy of Sciences of the United States of America. 102: 11462-7. PMID 16055558 DOI: 10.1073/pnas.0503230102  0.74
2005 Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. Journal of Virology. 79: 10589-600. PMID 16051851 DOI: 10.1128/Jvi.79.16.10589-10600.2005  0.759
2005 Azkur AK, Kim B, Suvas S, Lee Y, Kumaraguru U, Rouse BT. Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides. 15: 72-84. PMID 15989422 DOI: 10.1089/Oli.2005.15.72  0.504
2005 Kim B, Lee S, Suvas S, Rouse BT. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. Journal of Immunology (Baltimore, Md. : 1950). 175: 509-16. PMID 15972686 DOI: 10.4049/Jimmunol.175.1.509  0.383
2005 Biswas PS, Rouse BT. Early events in HSV keratitis--setting the stage for a blinding disease. Microbes and Infection / Institut Pasteur. 7: 799-810. PMID 15857807 DOI: 10.1016/J.Micinf.2005.03.003  0.645
2005 Pack CD, Kumaraguru U, Suvas S, Rouse BT. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Vaccine. 23: 3526-34. PMID 15855011 DOI: 10.1016/J.Vaccine.2005.01.152  0.466
2005 Toka FN, Rouse BT. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. Journal of Leukocyte Biology. 78: 178-86. PMID 15817700 DOI: 10.1189/Jlb.1004621  0.489
2005 Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nature Immunology. 6: 353-60. PMID 15785761 DOI: 10.1038/Ni1181  0.481
2005 Biswas PS, Banerjee K, Kim B, Smith J, Rouse BT. A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis. Experimental Eye Research. 80: 73-81. PMID 15652528 DOI: 10.1016/J.Exer.2004.08.014  0.766
2005 Toka FN, Gieryńska M, Suvas S, Schoenberger SP, Rouse BT. Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation. Virology. 331: 151-8. PMID 15582662 DOI: 10.1016/J.Virol.2004.10.022  0.46
2005 Banerjee K, Biswas PS, Rouse BT. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. Journal of Leukocyte Biology. 77: 24-32. PMID 15496448 DOI: 10.1189/Jlb.0904486  0.798
2005 Schmid DS, Rouse BT. Respiratory viral vaccines Mucosal Immunology, Two-Volume Set. 923-936. DOI: 10.1016/B978-012491543-5/50055-3  0.382
2004 Banerjee K, Biswas PS, Kumaraguru U, Schoenberger SP, Rouse BT. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. Journal of Immunology (Baltimore, Md. : 1950). 173: 7575-83. PMID 15585885 DOI: 10.4049/Jimmunol.173.12.7575  0.805
2004 Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY, Ansari AM, Scaria PV, Woodle MC, Lu P, Rouse BT. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. The American Journal of Pathology. 165: 2177-85. PMID 15579459 DOI: 10.1016/S0002-9440(10)63267-1  0.6
2004 Toka FN, Suvas S, Rouse BT. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. Journal of Virology. 78: 13082-9. PMID 15542660 DOI: 10.1128/Jvi.78.23.13082-13089.2004  0.468
2004 Rouse BT, Suvas S. Regulatory cells and infectious agents: detentes cordiale and contraire. Journal of Immunology (Baltimore, Md. : 1950). 173: 2211-5. PMID 15294929 DOI: 10.4049/Jimmunol.173.4.2211  0.486
2004 Biswas PS, Banerjee K, Zheng M, Rouse BT. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. Journal of Leukocyte Biology. 76: 868-75. PMID 15258192 DOI: 10.1189/Jlb.0504280  0.743
2004 Toka FN, Pack CD, Rouse BT. Molecular adjuvants for mucosal immunity. Immunological Reviews. 199: 100-12. PMID 15233729 DOI: 10.1111/J.0105-2896.2004.0147.X  0.398
2004 Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Reviews in Molecular Medicine. 6: 1-14. PMID 15061872 DOI: 10.1017/S1462399404007604  0.779
2004 Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. Journal of Immunology (Baltimore, Md. : 1950). 172: 4123-32. PMID 15034024 DOI: 10.4049/Jimmunol.172.7.4123  0.528
2004 Biswas PS, Banerjee K, Kim B, Rouse BT. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 172: 3736-44. PMID 15004178 DOI: 10.4049/Jimmunol.172.6.3736  0.739
2004 Kumaraguru U, Suvas S, Biswas PS, Azkur AK, Rouse BT. Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 3719-24. PMID 15004176 DOI: 10.4049/Jimmunol.172.6.3719  0.618
2004 Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. Journal of Immunology (Baltimore, Md. : 1950). 172: 1237-45. PMID 14707102 DOI: 10.4049/Jimmunol.172.2.1237  0.775
2003 Kumaraguru U, Gouffon CA, Ivey RA, Rouse BT, Bruce BD. Antigenic peptides complexed to phylogenically diverse Hsp70s induce differential immune responses. Cell Stress & Chaperones. 8: 134-43. PMID 14627199 DOI: 10.1379/1466-1268(2003)008<0134:Apctpd>2.0.Co;2  0.381
2003 Toka FN, Gierynska M, Rouse BT. Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. Journal of Virology. 77: 12742-52. PMID 14610196 DOI: 10.1128/Jvi.77.23.12742-12752.2003  0.417
2003 Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. The Journal of Experimental Medicine. 198: 889-901. PMID 12975455 DOI: 10.1084/Jem.20030171  0.485
2003 Lee Y, Eo SK, Rouse RJ, Rouse BT. Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. Virology. 312: 169-80. PMID 12890630 DOI: 10.1016/S0042-6822(03)00199-5  0.646
2003 Lee S, Gierynska M, Eo SK, Kuklin N, Rouse BT. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes and Infection / Institut Pasteur. 5: 571-8. PMID 12787733 DOI: 10.1016/S1286-4579(03)00108-4  0.418
2003 Kumaraguru U, Pack CD, Rouse BT. Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins. Journal of Leukocyte Biology. 73: 574-83. PMID 12714571 DOI: 10.1189/Jlb.0902470  0.403
2002 Klinman DM, Zheng M, Gierynska M, Rouse BT. DNA Containing Bioactive CpG Motifs Promote Angiogenesis. Drug News & Perspectives. 15: 358-363. PMID 12677232 DOI: 10.1358/Dnp.2002.15.6.840034  0.333
2002 Banerjee K, Deshpande S, Zheng M, Kumaraguru U, Schoenberger SP, Rouse BT. Herpetic stromal keratitis in the absence of viral antigen recognition. Cellular Immunology. 219: 108-18. PMID 12576029 DOI: 10.1016/S0008-8749(02)00601-9  0.803
2002 Blackman MA, Rouse BT, Chisari FV, Woodland DL. Viral immunology: challenges associated with the progression from bench to clinic. Trends in Immunology. 23: 565-7. PMID 12464561 DOI: 10.1016/S1471-4906(02)02343-8  0.422
2002 Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. The Journal of Clinical Investigation. 110: 1105-11. PMID 12393846 DOI: 10.1172/Jci15755  0.35
2002 Kumaraguru U, Rouse BT. The IL-12 response to herpes simplex virus is mainly a paracrine response of reactive inflammatory cells. Journal of Leukocyte Biology. 72: 564-70. PMID 12223525 DOI: 10.1189/Jlb.72.3.564  0.471
2002 Zheng M, Klinman DM, Gierynska M, Rouse BT. DNA containing CpG motifs induces angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 99: 8944-9. PMID 12060721 DOI: 10.1073/Pnas.132605599  0.353
2002 Gierynska M, Kumaraguru U, Eo SK, Lee S, Krieg A, Rouse BT. Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. Journal of Virology. 76: 6568-76. PMID 12050369 DOI: 10.1128/Jvi.76.13.6568-6576.2002  0.483
2002 Rouse BT, Deshpande S. Viruses and autoimmunity: an affair but not a marriage contract. Reviews in Medical Virology. 12: 107-13. PMID 11921306 DOI: 10.1002/Rmv.347  0.651
2002 Deshpande SP, Zheng M, Lee S, Rouse BT. Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Veterinary Microbiology. 86: 17-26. PMID 11888686 DOI: 10.1016/S0378-1135(01)00487-4  0.652
2002 Lee S, Zheng M, Deshpande S, Eo SK, Hamilton TA, Rouse BT. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. Journal of Leukocyte Biology. 71: 469-76. PMID 11867684 DOI: 10.1189/Jlb.71.3.469  0.663
2002 Kumaraguru U, Gierynska M, Norman S, Bruce BD, Rouse BT. Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection. Journal of Virology. 76: 136-41. PMID 11739679 DOI: 10.1128/Jvi.76.1.136-141.2002  0.494
2002 Eo SK, Lee S, Kumaraguru U, Rouse BT. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands. Vaccine. 19: 4685-93. PMID 11535317 DOI: 10.1016/S0264-410X(01)00241-9  0.462
2001 Rouse BT, Gierynska M. Immunity to herpes simplex virus: A hypothesis Herpes. 8. PMID 11867027  0.356
2001 Eo SK, Pack C, Kumaraguru U, Rouse BT. Optimisation of DNA vaccines for thé prophylaxis and modulation of herpes simplex virus infections Expert Opinion On Biological Therapy. 1: 213-225. PMID 11727531 DOI: 10.1517/14712598.1.2.213  0.358
2001 Seong Kug Eo, Kumaraguru U, Rouse BT. Plasmid DNA encoding CCR7 ligands compensate for dysfunctional CD8+ T cell responses by effects on dendritic cells Journal of Immunology. 167: 3592-3599. PMID 11564771 DOI: 10.4049/Jimmunol.167.7.3592  0.493
2001 Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. Journal of Virology. 75: 9828-35. PMID 11559816 DOI: 10.1128/Jvi.75.20.9828-9835.2001  0.645
2001 Zheng M, Schwarz MA, Lee S, Kumaraguru U, Rouse BT. Control of stromal keratitis by inhibition of neovascularization. The American Journal of Pathology. 159: 1021-9. PMID 11549594 DOI: 10.1016/S0002-9440(10)61777-4  0.411
2001 Deshpande S, Zheng M, Lee S, Banerjee K, Gangappa S, Kumaraguru U, Rouse BT. Bystander activation involving T lymphocytes in herpetic stromal keratitis. Journal of Immunology (Baltimore, Md. : 1950). 167: 2902-10. PMID 11509638 DOI: 10.4049/Jimmunol.167.5.2902  0.797
2001 Eo SK, Gierynska M, Kamar AA, Rouse BT. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. Journal of Immunology (Baltimore, Md. : 1950). 166: 5473-9. PMID 11313385 DOI: 10.4049/Jimmunol.166.9.5473  0.367
2001 Deshpande SP, Lee S, Zheng M, Song B, Knipe D, Kapp JA, Rouse BT. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. Journal of Virology. 75: 3077-88. PMID 11238834 DOI: 10.1128/Jvi.75.7.3077-3088.2001  0.699
2001 Mistry SK, Zheng M, Rouse BT, Morris SM. Induction of arginases I and II in cornea during herpes simplex virus infection. Virus Research. 73: 177-82. PMID 11172921 DOI: 10.1016/S0168-1702(00)00243-4  0.413
2001 Kumaraguru U, Davis IA, Deshpande S, Tevethia SS, Rouse BT. Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. Journal of Immunology (Baltimore, Md. : 1950). 166: 1066-74. PMID 11145686 DOI: 10.4049/Jimmunol.166.2.1066  0.696
2001 Eo SK, Lee S, Chun S, Rouse BT. Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. Journal of Virology. 75: 569-78. PMID 11134269 DOI: 10.1128/Jvi.75.2.569-578.2001  0.47
2000 Eo SK, Chun S, Lee S, Rouse BT. On the mechanisms of T cell silencing by IL-10 DNA: Direct and indirect inhibition of T cell functions Cellular Immunology. 206: 59-69. PMID 11161438 DOI: 10.1006/Cimm.2000.1731  0.428
2000 Deshpande SP, Kumaraguru U, Rouse BT. Why do we lack an effective vaccine against herpes simplex virus infections? Microbes and Infection / Institut Pasteur. 2: 973-8. PMID 10962281 DOI: 10.1016/S1286-4579(00)00339-7  0.628
2000 Deshpande SP, Kumaraguru U, Rouse BT. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections. Cellular Immunology. 202: 79-87. PMID 10896767 DOI: 10.1006/Cimm.2000.1666  0.718
2000 Kumaraguru U, Rouse RJ, Nair SK, Bruce BD, Rouse BT. Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization. Journal of Immunology (Baltimore, Md. : 1950). 165: 750-9. PMID 10878348 DOI: 10.4049/Jimmunol.165.2.750  0.379
2000 Kumaraguru U, Rouse BT. Application of the intracellular gamma interferon assay to recalculate the potency of CD8+ T-cell responses to herpes simplex virus Journal of Virology. 74: 5709-5711. PMID 10823879 DOI: 10.1128/Jvi.74.12.5709-5711.2000  0.499
2000 Deshpande SP, Zheng M, Daheshia M, Rouse BT. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. Journal of Virology. 74: 3517-24. PMID 10729125 DOI: 10.1128/Jvi.74.8.3517-3524.2000  0.669
2000 Gangappa S, Deshpande SP, Rouse BT. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Investigative Ophthalmology & Visual Science. 41: 453-9. PMID 10670475  0.699
1999 Gangappa S, Deshpande SP, Rouse BT. Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. European Journal of Immunology. 29: 3674-82. PMID 10556823 DOI: 10.1002/(Sici)1521-4141(199911)29:11<3674::Aid-Immu3674>3.0.Co;2-7  0.721
1999 Chun S, Daheshia M, Lee S, Rouse BT. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy. Cellular Immunology. 194: 194-204. PMID 10383822 DOI: 10.1006/Cimm.1999.1500  0.395
1999 Daheshia M, Deshpande S, Chun S, Kuklin NA, Rouse BT. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice. Virology. 257: 168-76. PMID 10208930 DOI: 10.1006/Viro.1999.9613  0.706
1999 Kumaraguru U, Davis I, Rouse BT. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus Journal of Neurovirology. 5: 42-47. PMID 10190689 DOI: 10.3109/13550289909029744  0.466
1998 Banks TA, Hariharan MJ, Rouse BT. Assessing Cell-Mediated Immune Responses to HSV in Murine Systems. Methods in Molecular Medicine. 10: 327-43. PMID 21374239 DOI: 10.1385/0-89603-347-3:327  0.504
1998 Daheshia M, Feldman LT, Rouse BT. Herpes simplex virus latency and the immune response Current Opinion in Microbiology. 1: 430-435. PMID 10066506 DOI: 10.1016/S1369-5274(98)80061-1  0.463
1998 Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea Experimental Eye Research. 67: 619-624. PMID 9990326 DOI: 10.1006/Exer.1998.0565  0.547
1998 Davis IA, Rouse BT. Immune responsiveness of lymphotoxin-α-deficient mice: Two reconstitution models Cellular Immunology. 189: 116-124. PMID 9790725 DOI: 10.1006/Cimm.1998.1371  0.371
1998 Davis IA, Knight KA, Rouse BT. The spleen and organized lymph nodes are not essential for the development of gut-induced mucosal immune responses in lymphotoxin-α deficient mice Clinical Immunology and Immunopathology. 89: 150-159. PMID 9787117 DOI: 10.1006/Clin.1998.4601  0.372
1998 Thomas J, Kanangat S, Rouse BT. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: Implications in herpetic stromal keratitis Journal of Interferon and Cytokine Research. 18: 681-690. PMID 9781806 DOI: 10.1089/Jir.1998.18.681  0.489
1998 Manickan E, Daheshia M, Kuklin N, Chun S, Rouse BT. Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10. Immunology. 94: 129-34. PMID 9741332 DOI: 10.1046/J.1365-2567.1998.00496.X  0.474
1998 Yu Z, Karem KL, Kanangat S, Manickan E, Rouse BT. Protection by minigenes: a novel approach of DNA vaccines. Vaccine. 16: 1660-7. PMID 9713944 DOI: 10.1016/S0264-410X(98)00065-6  0.464
1998 Daheshia M, Kuklin N, Manickan E, Chun S, Rouse BT. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine. 16: 1103-10. PMID 9682365 DOI: 10.1016/S0264-410X(98)80105-9  0.409
1998 Kuklin NA, Daheshia M, Chun S, Rouse BT. Immunomodulation by mucosal gene transfer using TGF-β DNA Journal of Clinical Investigation. 102: 438-444. PMID 9664086 DOI: 10.1172/Jci2803  0.406
1998 Thomas J, Rouse BT. Immunopathology of herpetic stromal keratitis: Discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients Journal of Immunology. 160: 3965-3970. PMID 9558104  0.399
1998 Rouse BT, Nair S, Rouse RJ, Yu Z, Kuklin N, Karem K, Manickan E. DNA vaccines and immunity to herpes simplex virus. Current Topics in Microbiology and Immunology. 226: 69-78. PMID 9479836 DOI: 10.1007/978-3-642-80475-5_5  0.433
1998 Kuklin NA, Daheshia M, Marconi PC, Krisky DM, Rouse RJ, Glorioso JC, Manican E, Rouse BT. Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines. Virology. 240: 245-53. PMID 9454698 DOI: 10.1006/Viro.1997.8926  0.335
1998 Gangappa S, Manickan E, Rouse BT. Control of herpetic stromal keratitis using CTLA4Ig fusion protein Clinical Immunology and Immunopathology. 86: 88-94. PMID 9434800 DOI: 10.1006/Clin.1997.4460  0.528
1998 Kumaraguru U, Rouse BT. DNA vaccines for the prophylaxis and modulation of HSV infections Expert Opinion On Investigational Drugs. 7: 219-224. DOI: 10.1517/13543784.7.2.219  0.366
1998 Chun S, Daheshia M, Kuklin NA, Rouse BT. Modulation of Viral Immunoinflammatory Responses with Cytokine DNA Administered by Different Routes Journal of Virology. 72: 5545-5551. DOI: 10.1128/Jvi.72.7.5545-5551.1998  0.354
1997 Thomas J, Rouse BT. Immunopathogenesis of herpetic ocular disease Immunologic Research. 16: 375-386. PMID 9439761 DOI: 10.1007/Bf02786400  0.503
1997 Manickan E, Yu Z, Rouse BT. DNA immunization of neonates induces immunity despite the presence of maternal antibody Journal of Clinical Investigation. 100: 2371-2375. PMID 9410917 DOI: 10.1172/Jci119777  0.382
1997 Davis IA, Rouse BT. A skeptical look at viral immune evasion Frontiers in Bioscience : a Journal and Virtual Library. 2. PMID 9386215  0.306
1997 Manickan E, Karem KL, Rouse BT. DNA vaccines - A modern gimmick or a boon to vaccinology? Critical Reviews in Immunology. 17: 139-154. PMID 9094450 DOI: 10.1615/Critrevimmunol.V17.I2.20  0.301
1997 Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. Journal of Leukocyte Biology. 61: 125-32. PMID 9021916 DOI: 10.1002/Jlb.61.2.125  0.4
1997 Karem KL, Bowen J, Kuklin N, Rouse BT. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. The Journal of General Virology. 427-34. PMID 9018066 DOI: 10.1099/0022-1317-78-2-427  0.417
1997 Thomas J, Gangappa S, Kanangat S, Rouse BT. On the Essential Involvement of Neutrophils in the Immunopathologic Disease: Herpetic Stromal Keratitis Journal of Immunology. 158: 1383-1391. PMID 9013983  0.47
1997 Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. Journal of Virology. 71: 3138-3145. DOI: 10.1128/Jvi.71.4.3138-3145.1997  0.356
1996 Karem L K, Kanangat S, Rouse BT. Cytokine expression in the gut associated lymphoid tissue after oral administration of attenuated Salmonella vaccine strains Vaccine. 14: 1495-1502. PMID 9014289 DOI: 10.1016/S0264-410X(96)00118-1  0.394
1996 Rouse BT. Virus-induced immunopathology Advances in Virus Research. 47: 353-376. PMID 8895836 DOI: 10.1016/S0065-3527(08)60739-3  0.554
1996 Yu Z, Manickan E, Rouse BT. Role of interferon-γ in immunity to herpes simplex virus Journal of Leukocyte Biology. 60: 528-532. PMID 8864138 DOI: 10.1002/Jlb.60.4.528  0.558
1996 Manickan E, Yu Z, Rouse RJ, Wire WS, Rouse BT. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunology. 8: 53-61. PMID 8825290 DOI: 10.1089/Vim.1995.8.53  0.52
1996 Babu JS, Nair S, Kanda P, Rouse BT. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. Vaccine. 13: 1669-76. PMID 8719518 DOI: 10.1016/0264-410X(95)00120-P  0.408
1996 Bouley DM, Kanangat S, Rouse BT. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis Clinical Immunology and Immunopathology. 80: 23-30. PMID 8674236 DOI: 10.1006/Clin.1996.0090  0.521
1996 Kanangat S, Babu JS, Knipe DM, Rouse BT. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: Selective upregulation of IL-6 gene expression Virology. 219: 295-300. PMID 8623544 DOI: 10.1006/Viro.1996.0250  0.404
1996 Kanangat S, Blair P, Reddy R, Daheshia M, Godfrey V, Rouse BT, Wilkinson E, Deheshia M. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. European Journal of Immunology. 26: 161-5. PMID 8566060 DOI: 10.1002/Eji.1830260125  0.424
1996 Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus Journal of Virology. 70: 101-107. PMID 8523513 DOI: 10.1128/Jvi.70.1.101-107.1996  0.561
1996 Daheshia M, Kanangat S, Thomas J, Rouse BT. Expression of inducihle nitric oxide synihcta.se during occular herpes simplex viral infection Faseb Journal. 10.  0.334
1996 Kuklin N, Daheshia M, Karem K, Rouse BT. Intranasal administration of plasmid DNA encoding HSV glycoprotein B induces common mucosal immune response and protection against mucosal HSV challenge Faseb Journal. 10.  0.302
1996 Thomas J, Kanangat S, Knipe PM, Rouse BT. Viral replication is required for the expression of chemokines, proinflammalory cytokines and il-12 in the cornea for manifestation of hsk Faseb Journal. 10.  0.393
1995 Karem KL, Chatfield S, Kuklin N, Rouse BT. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice Infection and Immunity. 63: 4557-4563. PMID 7591105 DOI: 10.1128/Iai.63.12.4557-4563.1995  0.38
1995 Bouley DM, Kanangat S, Wire W, Rouse BT. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice Journal of Immunology. 155: 3964-3971. PMID 7561104  0.371
1995 Nair S, Buiting AM, Rouse RJ, Van Rooijen N, Huang L, Rouse BT. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. International Immunology. 7: 679-88. PMID 7547695 DOI: 10.1093/Intimm/7.4.679  0.387
1995 Kanangat S, Nair S, Babu JS, Rouse BT. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. Journal of Leukocyte Biology. 57: 310-6. PMID 7531747 DOI: 10.1002/Jlb.57.2.310  0.414
1995 Manickan E, Rouse BT. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models Journal of Virology. 69: 8178-8179. PMID 7494346  0.452
1995 Manickan E, Francotte M, Kuklin N, Dewerchin M, Molitor C, Gheysen D, Slaoui M, Rouse BT. Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells. Journal of Virology. 69: 4711-4716. DOI: 10.1128/Jvi.69.8.4711-4716.1995  0.516
1995 Niemialtowski M, Rouse BT. Evidence of involvement of CD4+ T cells and CD8+ cytotoxic T lymphocyte precursors (CTL-p) in response to intracorneal P511 minor histoincompatible allogeneic tumors Polish Journal of Immunology. 20: 45-55.  0.373
1994 Banks TA, Jenkins FJ, Kanangat S, Nair S, Dasgupta S, Foster CM, Rouse BT. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge. Virology. 200: 236-45. PMID 8128625 DOI: 10.1006/Viro.1994.1181  0.466
1994 Niemialtowski MG, Godfrey VL, Rouse BT. Quantitative studies on CD4<sup>+</sup> and CD8<sup>+</sup> cytotoxic T lymphocyte responses against herpes simplex virus type 1 in normal and β2-m deficient mice Immunobiology. 190: 183-194. PMID 7916329 DOI: 10.1016/S0171-2985(11)80268-8  0.409
1994 Niemiałtowski MG, Rouse BT. Cytotoxic T lymphocyte response to herpes simplex virus type 1 is composed of both CD8+ and CD4+ T cell phenotypes in acute and memory states Archivum Immunologiae Et Therapiae Experimentalis. 42: 319-324. PMID 7487374  0.328
1994 Rouse RJ, Nair SK, Lydy SL, Bowen JC, Rouse BT. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. Journal of Virology. 68: 5685-5689. DOI: 10.1128/Jvi.68.9.5685-5689.1994  0.472
1994 Niemialtowski MG, Rouse BT. Immunopathology of the herpetic stromal keratitis: Model studies Polish Journal of Immunology. 19: 289-311.  0.363
1994 Niemialtowski M, Kita J, Gierynska M, Rouse BT. The comparative analysis of human (HSV-1) and equine (EHV-1) herpes viruses. I. Structure of virion, its immunogenicity and humoral and cellular immunity during infection Polish Journal of Immunology. 19: 3-24.  0.359
1993 Daniel SL, Legendre AM, Moore RN, Rouse BT. Isolation and functional studies on feline bone marrow derived macrophages. Veterinary Immunology and Immunopathology. 36: 107-22. PMID 8475618 DOI: 10.1016/0165-2427(93)90101-9  0.33
1993 Mercadal CM, Slaoui M, Brown SM, Rouse BT. Efficacy of the herpes simplex virus types 1 and 2 mutant viruses to confer protection against zosteriform spread in mice. Viral Immunology. 6: 35-42. PMID 8386516 DOI: 10.1089/Vim.1993.6.35  0.477
1993 Martin S, Mercadal CM, Weir JP, Rouse BT. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoproteiC varies between individual mice and is dependent on the form of immunization Viral Immunology. 6: 21-33. PMID 8386515 DOI: 10.1089/Vim.1993.6.21  0.458
1993 Reiss CS, Rouse BT. The current status of viral immunology Immunology Today. 14: 333-335. PMID 8103337 DOI: 10.1016/0167-5699(93)90229-E  0.394
1993 Mercadal CM, Bouley DM, Destephano D, Rouse BT. Herpetic stromal keratitis in the reconstituted scid mouse model Journal of Virology. 67: 3404-3408. PMID 8098778 DOI: 10.1128/Jvi.67.6.3404-3408.1993  0.523
1993 Banks TA, Nair S, Rouse BT. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus Journal of Virology. 67: 613-616. PMID 7677961 DOI: 10.1128/Jvi.67.1.613-616.1993  0.375
1993 Nair S, Babu JS, Dunham RG, Kanda P, Burke RL, Rouse BT. Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. Journal of Virology. 67: 4062-4069. DOI: 10.1128/Jvi.67.7.4062-4069.1993  0.442
1992 Bowen JC, Daniel S, Rouse BT. Virus infections and cytokines: Can we manage the interactions¿? International Reviews of Immunology. 8: 33-41. PMID 1573318 DOI: 10.3109/08830189209056639  0.411
1992 Nair S, Zhou F, Reddy R, Huang L, Rouse BT. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. The Journal of Experimental Medicine. 175: 609-12. PMID 1531064 DOI: 10.1084/Jem.175.2.609  0.411
1992 Schmid DS, Rouse BT. The role of T cell immunity in control of herpes simplex virus Current Topics in Microbiology and Immunology. 179: 57-74. PMID 1499350 DOI: 10.1007/978-3-642-77247-4_4  0.482
1992 Doymaz MZ, Rouse BT. Immunopathology of herpes simplex virus infections Current Topics in Microbiology and Immunology. 179: 121-136. PMID 1499346 DOI: 10.1007/978-3-642-77247-4_8  0.505
1992 Nair S, Zhou X, Huang L, Rouse BT. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines Journal of Immunological Methods. 152: 237-243. PMID 1386866 DOI: 10.1016/0022-1759(92)90145-J  0.336
1992 Zhou F, Rouse BT, Huang L. Prolonged Survival of Thymomabearing Mice after Vaccination with a Soluble Protein Antigen Entrapped in Liposomes: A Model Study Cancer Research. 52: 6287-6291. PMID 1384958  0.34
1992 Doymaz MZ, Rouse BT. Herpetic stromal keratitis: An immunopathologic disease mediated by CD4+ T lymphocytes Investigative Ophthalmology and Visual Science. 33: 2165-2173. PMID 1351475  0.411
1992 Coker LA, Mercadal CM, Rouse BT, Moore RN. Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. Journal of Leukocyte Biology. 51: 305-6. PMID 1347313 DOI: 10.1002/Jlb.51.3.305  0.36
1992 Niemialtowski MG, Rouse BT. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye Journal of Immunology. 148: 1864-1870. PMID 1347309  0.361
1992 Banks TA, Rouse BT. Herpesviruses-immune escape artists? Clinical Infectious Diseases. 14: 933-941. PMID 1315587 DOI: 10.1093/Clinids/14.4.933  0.432
1991 Allen EM, Weir JP, Martin S, Mercadal C, Rouse BT. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity. Viral Immunology. 3: 207-15. PMID 2175194 DOI: 10.1089/Vim.1990.3.207  0.419
1991 Doymaz MZ, Foster CM, Destephano D, Rouse BT. MHC II-restricted, CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice. Clinical Immunology and Immunopathology. 61: 398-409. PMID 1934628 DOI: 10.1016/S0090-1229(05)80011-X  0.455
1991 Mester JC, Glorioso JC, Rouse BT. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. The Journal of Infectious Diseases. 163: 263-9. PMID 1846388 DOI: 10.1093/Infdis/163.2.263  0.376
1991 Mercadal CM, Martin S, Rouse BT. Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation Viral Immunology. 4: 177-186. PMID 1687350 DOI: 10.1089/Vim.1991.4.177  0.481
1991 Mester JC, Rouse BT. The mouse model and understanding immunity to herpes simplex virus Reviews of Infectious Diseases. 13: S935-S945. PMID 1664131 DOI: 10.1093/clind/13.Supplement_11.S935  0.389
1991 Banks TA, Allen EM, Dasgupta S, Sandri-Goldin R, Rouse BT. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27. Journal of Virology. 65: 3185-3191. DOI: 10.1128/Jvi.65.6.3185-3191.1991  0.465
1990 Kolaitis G, Doymaz M, Rouse BT. Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus Immunology. 71: 101-106. PMID 2210799  0.362
1990 Martin S, Zhu X, Silverstein SJ, Courtney RJ, Yao F, Jenkins FJ, Rouse BT. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0 Journal of General Virology. 71: 2391-2399. PMID 2172452 DOI: 10.1099/0022-1317-71-10-2391  0.479
1990 Brynestad K, Babbitt B, Huang L, Rouse BT. Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: Implications for subunit vaccines Journal of Virology. 64: 680-685. PMID 2153234 DOI: 10.1128/Jvi.64.2.680-685.1990  0.326
1989 Horohov DW, Moore RN, Rouse BT. The regulation of herpes simplex virus-specific CTL induction by suppressor cells. Viral Immunology. 1: 55-68. PMID 2855699 DOI: 10.1089/Vim.1987.1.55  0.509
1989 Weir JP, Bennett M, Allen EM, Elkins KL, Martin S, Rouse BT. Recombinant vaccinia virus expressing the herpes simplex virus Type 1 glycoprotein C protects mice against herpes simplex virus challenge Journal of General Virology. 70: 2587-2594. PMID 2794972 DOI: 10.1099/0022-1317-70-10-2587  0.491
1989 Rouse BT, Hartley D, Doherty PC. Consequences of exposure to ionizing radiation for effector T cell function in vivo Viral Immunology. 2: 69-78. PMID 2789064 DOI: 10.1089/Vim.1989.2.69  0.506
1989 Martin S, Cantin E, Rouse BT. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins Journal of General Virology. 70: 1359-1370. PMID 2543783 DOI: 10.1099/0022-1317-70-6-1359  0.541
1989 Newell CK, Sendele D, Rouse BT. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis Regional Immunology. 2: 366-369. PMID 2518571  0.316
1989 Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. Journal of Virology. 63: 769-775. DOI: 10.1128/Jvi.63.2.769-775.1989  0.493
1988 Martin S, Cantin E, Rouse BT. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections Annals of the New York Academy of Sciences. 532: 257-272. PMID 2845846 DOI: 10.1111/J.1749-6632.1988.Tb36344.X  0.497
1988 Ho RJ, Ting-Beall HP, Rouse BT, Huang L. Kinetic and ultrastructural studies of interactions of target-sensitive immunoliposomes with herpes simplex virus. Biochemistry. 27: 500-6. PMID 2831962 DOI: 10.1021/Bi00401A072  0.341
1988 Wyckoff JH, Osmand AP, Eisenberg RJ, Cohen GH, Rouse BT. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D Immunobiology. 177: 134-148. PMID 2456985 DOI: 10.1016/S0171-2985(88)80034-2  0.416
1988 Rouse BT, Norley S, Martin S. Antiviral cytotoxic t lymphocyte induction and vaccination Reviews of Infectious Diseases. 10: 16-33. PMID 2451265 DOI: 10.1093/Clinids/10.1.16  0.515
1988 Martin S, Courtney RJ, Fowler G, Rouse BT. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. Journal of Virology. 62: 2265-2273. DOI: 10.1128/Jvi.62.7.2265-2273.1988  0.521
1987 Lathey JL, Courtney RJ, Rouse BT. Production, binding characteristics, and immunogenicity of heterologous anti-idiotypic antibody to herpes simplex virus glycoprotein C Viral Immunology. 1: 13-23. PMID 3509672 DOI: 10.1089/Vim.1987.1.13  0.304
1987 Lathey JL, Martin S, Rouse BT. Suppression of delayed type hypersensitivity to herpes simplex virus type 1 following immunization with anti-idiotypic antibody: An example of split tolerance Journal of General Virology. 68: 1093-1102. PMID 3033128 DOI: 10.1099/0022-1317-68-4-1093  0.476
1987 Martin S, Rouse BT. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing Herpes simplex virus type 1 glycoprotein D: Clearance of local infection Journal of Immunology. 138: 3431-3437. PMID 3033075  0.434
1987 Martin S, Moss B, Berman PW, Laskey LA, Rouse BT. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. Journal of Virology. 61: 726-734. DOI: 10.1128/jvi.61.3.726-734.1987  0.366
1986 Rouse BT, Horohov DW. Immunosuppression in viral infections Reviews of Infectious Diseases. 8: 850-873. PMID 3025993 DOI: 10.1093/Clinids/8.6.850  0.515
1986 Turtinen LW, Lathey JL, Rouse BT. Estimation of the B lymphocyte precursor frequencies to herpes simplex type 1 glycoproteins by a limiting dilution assay Journal of Medical Virology. 20: 357-362. PMID 3025354 DOI: 10.1002/Jmv.1890200408  0.32
1986 Ho RJ, Rouse BT, Huang L. Destabilization of target-sensitive immunoliposomes by antigen binding--a rapid assay for virus. Biochemical and Biophysical Research Communications. 138: 931-7. PMID 3017345 DOI: 10.1016/S0006-291X(86)80585-X  0.448
1986 Horohov DW, Wyckoff JH, Moore RN, Rouse BT. Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor Journal of Virology. 58: 331-338. PMID 3009850 DOI: 10.1128/Jvi.58.2.331-338.1986  0.463
1986 Horohov DW, Moore RN, Rouse BT. Herpes simplex virus-specific lymphoproliferation: an analysis of the involvement of lymphocyte subsets. Immunobiology. 170: 460-73. PMID 3005161 DOI: 10.1016/S0171-2985(85)80069-3  0.495
1986 Norley SG, Huang L, Rouse BT. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: An effective means of inhibiting virus replication in vitro Journal of Immunology. 136: 681-685. PMID 3001182  0.314
1986 Horohov DW, Rouse BT. Virus-induced immunosuppression Veterinary Clinics of North America - Small Animal Practice. 16: 1097-1127. PMID 2947378 DOI: 10.1016/S0195-5616(86)50131-5  0.489
1986 Horohov DW, Wyckoff JH, Moore RN, Rouse BT. Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor. Journal of Virology. 58: 331-338. DOI: 10.1128/jvi.58.2.331-338.1986  0.34
1985 Horohov DW, Moore RN, Rouse BT. Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells Journal of Virology. 56: 1-6. PMID 2993641 DOI: 10.1128/Jvi.56.1.1-6.1985  0.465
1985 Horohov DW, Moore RN, Rouse BT. Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice Journal of Virology. 54: 798-803. PMID 2987531 DOI: 10.1128/Jvi.54.3.798-803.1985  0.478
1985 Prymowicz D, Moore RN, Rouse BT. Frequency of herpes simplex virus-specific helper T lymphocyte precursors in the lymph node cells of infected mice Journal of Immunology. 134: 2683-2688. PMID 2579150  0.372
1984 Moore RN, Larsen HS, Horohov DW, Rouse BT. Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science (New York, N.Y.). 223: 178-81. PMID 6606850 DOI: 10.1126/Science.6606850  0.329
1984 Rouse BT, Horohov DW. Cytotoxic T lymphocytes in herpesvirus infections Veterinary Immunology and Immunopathology. 6: 35-66. PMID 6330966 DOI: 10.1016/0165-2427(84)90048-5  0.315
1984 Rouse BT, Wagner H. Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice Immunology. 51: 57-64. PMID 6317545  0.396
1984 Larsen HS, Feng MF, Horohov DW, Moore RN, Rouse BT. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. Journal of Virology. 50: 56-59. DOI: 10.1128/Jvi.50.1.56-59.1984  0.458
1983 Rouse BT, Larsen HS, Wagner H. Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis Infection and Immunity. 39: 785-792. PMID 6299949 DOI: 10.1128/Iai.39.2.785-792.1983  0.517
1983 Schmid DS, Rouse BT. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: Differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors Journal of Immunology. 131: 479-484. PMID 6223080  0.411
1983 Larsen HS, Russell RG, Rouse BT. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infection and Immunity. 41: 197-204. DOI: 10.1128/Iai.41.1.197-204.1983  0.507
1982 Wagner H, Hardt C, Rouse BT, Röllinghoff M, Scheurich P, Pfizenmaier K. Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. The Journal of Experimental Medicine. 155: 1876-81. PMID 6978927 DOI: 10.1084/Jem.155.6.1876  0.373
1982 Schmid DS, Larsen HS, Rouse BT. Role of Ia antigen expression and secretory function of accessory cells in the induction of cytotoxic T lymphocyte responses against herpes simplex virus Infection and Immunity. 37: 1138-1147. PMID 6290391 DOI: 10.1128/Iai.37.3.1138-1147.1982  0.437
1982 Naylor PT, Larsen HS, Huang L, Rouse BT. In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes Infection and Immunity. 36: 1209-1216. PMID 6284643 DOI: 10.1128/Iai.36.3.1209-1216.1982  0.452
1981 Eberle R, Russell RG, Rouse BT. Cell-mediated immunity to herpes simplex virus: Recognition of type-specific and type-common surface antigens by cytotoxic T cell populations Infection and Immunity. 34: 795-803. PMID 6277790 DOI: 10.1128/Iai.34.3.795-803.1981  0.496
1981 Kohl S, Lawman MJ, Rouse BT, Cahall DL. Effect of herpes simplex virus infection on murine antibody-dependent cellular cytotoxicity and natural killer cytotoxicity. Infection and Immunity. 31: 704-711. DOI: 10.1128/iai.31.2.704-711.1981  0.334
1980 Grewal AS, Rouse BT. Destruction of virus infected cells by neutrophils and complement Experientia. 36: 352-354. PMID 6245915 DOI: 10.1007/BF01952322  0.364
1980 Rouse BT, Lawman MJP. Induction of cytotoxic T lymphocytes against herpes simplex virus type I: Role of accessory cells and amplifying factor Journal of Immunology. 124: 2341-2346. PMID 6245140  0.399
1980 Rouse BT, Babiuk LA, Henson PM. Neutrophils in antiviral immunity: Inhibition of virus replication by a mediator produced by bovine neutrophils Journal of Infectious Diseases. 141: 223-232. PMID 6154112 DOI: 10.1093/Infdis/141.2.223  0.452
1980 Lawman MJ, Rouse BT, Courtney RJ, Walker RD. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infection and Immunity. 27: 133-139. DOI: 10.1128/Iai.27.1.133-139.1980  0.547
1979 Grewal AS, Rouse BT. Characterization of bovine leukocytes involved in antibody-dependent cell cytotoxicity. International Archives of Allergy and Applied Immunology. 60: 169-77. PMID 468390 DOI: 10.1159/000232339  0.316
1979 Rouse BT, Babiuk LA. Mechanisms of viral immunopathology Advances in Veterinary Science and Comparative Medicine. 23: 103-136. PMID 317775 DOI: 10.1016/B978-0-12-039223-0.50011-1  0.497
1979 Babiuk LA, Rouse BT. Immune control of herpesvirus latency Canadian Journal of Microbiology. 25: 267-274. PMID 222416  0.338
1978 Fujimiya Y, Rouse BT, Babiuk L. Human neutrophil mediated destruction of antibody sensitized herpes simplex virus type I infected cells Canadian Journal of Microbiology. 24: 182-186. PMID 565669 DOI: 10.1139/M78-031  0.47
1978 Rouse BT, Babiuk LA. Mechanisms of recovery from Herpesvirus infections -a review Canadian Journal of Comparative Medicine. 42: 414-427. PMID 217506  0.388
1978 Fujimiya Y, Babiuk LA, Rouse BT. Direct lymphocytotoxicity against herpes simplex virus infected cells Canadian Journal of Microbiology. 24: 1076-1081. PMID 213180 DOI: 10.1139/M78-177  0.467
1978 Rouse BT, Babiuk LA, Henson PM. Neutrophils are mediators of antiviral immunity Experientia. 34: 346-348. PMID 204508 DOI: 10.1007/Bf01923026  0.397
1978 Babiuk LA, Rouse BT. Interactions between effector cell activity and lymphokines: implications for recovery from herpesvirus infections International Archives of Allergy and Applied Immunology. 57: 62-73. PMID 25244 DOI: 10.1159/000232085  0.502
1977 Rouse BT, Grewal AS, Babiuk LA, Fujimiya Y. Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement Infection and Immunity. 18: 660-665. PMID 201564 DOI: 10.1128/Iai.18.3.660-665.1977  0.4
1977 Babiuk LA, Rouse BT. Bovine type II interferon: activity in heterologous cells Intervirology. 8: 250-256. PMID 194868 DOI: 10.1159/000148900  0.325
1977 Grewal AS, Rouse BT, Babiuk LA. Mechanisms of resistance to herpesviruses: comparison of the effectiveness of different cell types in mediating antibody dependent cell mediated cytotoxicity Infection and Immunity. 15: 698-703. PMID 192672 DOI: 10.1128/Iai.15.3.698-703.1977  0.432
1977 Rouse BT, Babiuk LA. The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells Journal of Immunology. 118: 618-624. PMID 190317  0.367
1977 Rouse BT, Grewal AS, Babiuk LA, Fujimiya Y. Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement. Infection and Immunity. 18: 660-665. DOI: 10.1128/iai.18.3.660-665.1977  0.307
1976 Rouse BT, Wardley RC, Babiuk LA. Antibody dependent cell mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erythrocyte and herpesvirus infected bovine target cells Infection and Immunity. 13: 1433-1441. PMID 1270149 DOI: 10.1128/Iai.13.5.1433-1441.1976  0.454
1976 Babiuk LA, Rouse BT. Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses Infection and Immunity. 13: 1567-1578. PMID 1085748  0.361
1976 Wardley RC, Babiuk LA, Rouse BT. Polymorph mediated antibody dependent cytotoxicity: modulation of activity by drugs and immune interferon Canadian Journal of Microbiology. 22: 1222-1228. PMID 184903 DOI: 10.1139/M76-181  0.449
1976 Rouse BT, Wardley RC, Babiuk LA. The role of antibody dependent cytotoxicity in recovery from herpesvirus infections Cellular Immunology. 22: 182-186. PMID 179716 DOI: 10.1016/0008-8749(76)90019-8  0.373
1975 Rouse BT, Babiuk LA. Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes Cellular Immunology. 17: 43-56. PMID 165005 DOI: 10.1016/S0008-8749(75)80005-0  0.36
1975 Rouse BT, Babiuk L. Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages Infection and Immunity. 11: 505-511. PMID 163796 DOI: 10.1128/Iai.11.3.505-511.1975  0.459
1975 Babiuk LA, Wardley RC, Rouse BT. Defense mechanisms against bovine herpesvirus: relationship of virus host cell events to susceptibility to antibody complement cell lysis Infection and Immunity. 12: 958-963. PMID 53206 DOI: 10.1128/Iai.12.5.958-963.1975  0.467
1974 Rouse BT, Babiuk LA. Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen Infection and Immunity. 10: 681-687. PMID 4426702 DOI: 10.1128/Iai.10.4.681-687.1974  0.458
1974 Rouse BT, Babiuk LA. Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes Journal of Immunology. 113: 1391-1398. PMID 4370600  0.353
1973 Rouse BT, Wagner H. The in vivo activity of in vitro immunized mouse thymocytes: III fate of in vitro immunized thymocytes Transplantation. 16: 161-170. PMID 4199580 DOI: 10.1097/00007890-197309000-00001  0.357
1969 Narayan O, Lang G, Rouse BT. A new influenza A virus infection in turkeys - IV. Experimental susceptibility of domestic birds to virus strain turkey/Ontario 7732/1966 Archiv FüR Die Gesamte Virusforschung. 26: 149-165. PMID 4306362 DOI: 10.1007/BF01241184  0.302
Low-probability matches (unlikely to be authored by this person)
1975 Babiuk LA, Wardley RC, Rouse BT. Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infection and Immunity. 12: 958-963. DOI: 10.1128/iai.12.5.958-963.1975  0.299
1982 Naylor PT, Larsen HS, Huang L, Rouse BT. In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes. Infection and Immunity. 36: 1209-1216. DOI: 10.1128/iai.36.3.1209-1216.1982  0.299
1992 Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis Journal of Immunology. 149: 3035-3039. PMID 1357034  0.299
1996 Karem KL, Kanagat S, Rouse BT. In vivo cytokine expression in the Gut Associated Lymphoid Tissue (G.A.L.T.) after oral immunization with attenuated Salmonella vaccine strains Faseb Journal. 10.  0.298
1970 Narayan O, Rouse BT, Lang G. A new influenza A virus infection in turkeys. VI. Artificial immunization against the malignant virus strain turkey-Ontario 7732-66. Canadian Journal of Comparative Medicine. Revue Canadienne De Mã©Decine Comparã©E. 34: 72-9. PMID 4246007  0.296
1976 Rouse BT, Wardley RC, Babiuk LA. Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infection and Immunity. 13: 1433-1441. DOI: 10.1128/iai.13.5.1433-1441.1976  0.295
2020 Sumbria D, Berber E, Mathayan M, Rouse BT. Virus Infections and Host Metabolism-Can We Manage the Interactions? Frontiers in Immunology. 11: 594963. PMID 33613518 DOI: 10.3389/fimmu.2020.594963  0.294
2020 Dubey A, Dahiya S, Rouse BT, Sehrawat S. Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology. Frontiers in Immunology. 11: 581076. PMID 33193385 DOI: 10.3389/fimmu.2020.581076  0.29
1968 Rouse BT, Lang G, Narayan O. A new influenza a virus infection in turkeys. III. Pathology of the experimental disease by virus strain Turkey/Ontario/6213/66 Journal of Comparative Pathology. 78. PMID 5682939  0.288
1994 Lathey JL, Kanangat S, Rouse BT, Agosti JM, Spector SA. Dysregulation of cytokine expression in monocytes from HIV-positive individuals. Journal of Leukocyte Biology. 56: 347-52. PMID 8083606 DOI: 10.1002/Jlb.56.3.347  0.286
1985 Moore RN, Pitruzzello FJ, Robinson RM, Rouse BT. Interferon produced endogenously in response to CSF-1 augments the functional differentiation of progeny macrophages. Journal of Leukocyte Biology. 37: 659-64. PMID 2580035 DOI: 10.1002/Jlb.37.5.659  0.285
2003 Kanangat S, Blair P, Reddy R, Daheshia M, Godrey V, Rouse BT, Wilkinson E. Correction: Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genesDisease in the scurfy (sf) mouse is associated with overexpression of cytokine genes (Eur. J. Immunol. 7/2003) European Journal of Immunology. 33: 2064-2064. DOI: 10.1002/Eji.200390035  0.281
2012 Kao CL, Chan TC, Tsai CH, Chu KY, Chuang SF, Lee CC, Li ZR, Wu KW, Chang LY, Shen YH, Huang LM, Lee PI, Yang C, Compans R, Rouse BT, et al. Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. Plos One. 7: e31162. PMID 22328930 DOI: 10.1371/Journal.Pone.0031162  0.279
2022 Rouse BT, Schmid DS. Fraternal Twins: The Enigmatic Role of the Immune System in Alphaherpesvirus Pathogenesis and Latency and Its Impacts on Vaccine Efficacy. Viruses. 14. PMID 35632603 DOI: 10.3390/v14050862  0.277
1977 Rouse BT, Babiuk LA, Gupta VS. The effect of the antiherpesvirus drug 5-methoxymethyl-2'-deoxyuridine on the humoral immune response in vivo. Canadian Journal of Microbiology. 23: 1059-61. PMID 196730  0.275
2006 Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity. 39: 71-7. PMID 16455584 DOI: 10.1080/08916930500484708  0.272
1992 Huang L, Reddy R, Nair SK, Zhou F, Rouse BT. Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation. Research in Immunology. 143: 192-6. PMID 1574646 DOI: 10.1016/S0923-2494(92)80164-G  0.272
1995 Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis Journal of Immunology. 154: 4822-4829. PMID 7722330  0.27
1975 Babiuk LA, Rouse BT. Effect of anti herpesvirus drugs on human and bovine lymphoid function in vitro Infection and Immunity. 12: 1281-1289. PMID 173654  0.269
1996 Babiuk LA, Rouse BT. Herpesvirus vaccines Advanced Drug Delivery Reviews. 21: 63-76. DOI: 10.1016/0169-409X(96)00017-8  0.268
1991 Reddy R, Zhou F, Huang L, Carbone F, Bevan M, Rouse BT. pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. Journal of Immunological Methods. 141: 157-63. PMID 1880423 DOI: 10.1016/0022-1759(91)90142-3  0.268
1985 Candler RV, Rouse BT, Moore RN. Regulation of interleukin 1 production by alpha and beta interferons: evidence for both direct and indirect enhancement. Journal of Interferon Research. 5: 179-89. PMID 3872917 DOI: 10.1089/Jir.1985.5.179  0.268
1992 Kanangat S, Solomon A, Rouse BT. Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules Molecular Immunology. 29: 1229-1236. PMID 1528193 DOI: 10.1016/0161-5890(92)90059-7  0.266
1997 Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. International Journal of Cancer. Journal International Du Cancer. 70: 706-15. PMID 9096653 DOI: 10.1002/(Sici)1097-0215(19970317)70:6<706::Aid-Ijc13>3.0.Co;2-7  0.264
1991 Zhou F, Rouse BT, Huang L. An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation Journal of Immunological Methods. 145: 143-152. PMID 1765645 DOI: 10.1016/0022-1759(91)90320-F  0.262
2008 Buch S, Rouse BT, Gendelman HE, Zink MC, Clements JE. Opendra "bill" Narayan (1936-2007): A personal tribute to a friend, teacher, and colleague Journal of Neuroimmune Pharmacology. 3: 1-4. DOI: 10.1007/S11481-008-9101-Y  0.262
1987 Ho RJ, Rouse BT, Huang L. Target-sensitive immunoliposomes: preparation and characterization. Biochemistry. 25: 5500-6. PMID 3022792 DOI: 10.1021/bi00367a023  0.261
1978 Grewal AS, Rouse BT, Babiuk LA. Characterization of surface receptors on bovine leukocytes International Archives of Allergy and Applied Immunology. 56: 289-300. PMID 631912 DOI: 10.1159/000232034  0.26
1972 Rouse BT, Warner NL. Induction of T cell tolerance in agammaglobulinemic chickens European Journal of Immunology. 2: 102-104. PMID 4404275  0.258
1994 Bowen JC, Nair SK, Reddy R, Rouse BT. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T- lymphocyte responses with non-replicating antigens Immunology. 81: 338-342. PMID 8206507  0.257
1990 Mester JC, Highlander SL, Osmand AP, Glorioso JC, Rouse BT. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B. Journal of Virology. 64: 5277-5283. DOI: 10.1128/jvi.64.11.5277-5283.1990  0.257
1999 Cormack B, Rouse BT, Beverley SM. Host-microbe interactions: Fungi/viruses/parasites editorial overview Current Opinion in Microbiology. 2: 343-347. PMID 10490350 DOI: 10.1016/S1369-5274(99)80060-5  0.254
1975 Babiuk LA, Meldrum B, Gupta VS, Rouse BT. Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrobial Agents and Chemotherapy. 8: 643-50. PMID 1239978  0.251
1994 Banks TA, Rouse BT. Current approaches and future directions in the treatment of herpesvirus infections Infections in Medicine. 11.  0.249
1969 Narayan O, Lang G, Rouse BT. A new influenza A virus infection in turkeys. V. Pathology of the experimental disease by strain turkey-Ontario 7732-66. Archiv Fã¼R Die Gesamte Virusforschung. 26: 166-82. PMID 4306363 DOI: 10.1007/BF01241185  0.245
1993 Babu JS, Kanangat S, Rouse BT. Limitations and modifications of quantitative polymerase chain reaction. Application to measurement of multiple mRNAs present in small amounts of sample RNA Journal of Immunological Methods. 165: 207-216. PMID 7693821 DOI: 10.1016/0022-1759(93)90346-9  0.243
1981 Larsen HS, Naylor PT, Rouse BT. Induction of anti-HSV immune responses by glycoprotein antigens incorporated into liposomes Federation Proceedings. 40.  0.243
2007 Banerjee K, Rouse BT. HSV: Immunopathological aspects of HSV infection Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 642-655. DOI: 10.1017/CBO9780511545313.036  0.242
1971 Rouse BT, Lang G, Narayan O. A new influenza A virus infection in turkeys. VII. Comparative immunology. Canadian Journal of Comparative Medicine. Revue Canadienne De Mã©Decine Comparã©E. 35: 44-51. PMID 4251414  0.241
1973 Röllinghoff M, Rouse BT, Warner NL. Tumor immunity to murine plasma cell tumors. I. tumor-associated transplantation antigens of nzb and balb/c plasma cell tumors23 Journal of the National Cancer Institute. 50: 159-172. PMID 4571237 DOI: 10.1093/jnci/50.1.159  0.238
1992 Ready R, Nair S, Brynestad K, Rouse BT. Liposomes as antigen delivery systems in viral immunity Seminars in Immunology. 4: 91-96. PMID 1535521  0.238
2021 Sehrawat S, Rouse BT. COVID-19: Disease, or no disease? - that is the question. It's the dose stupid! Microbes and Infection. 104779. PMID 33450356 DOI: 10.1016/j.micinf.2021.104779  0.233
1976 Wardley RC, Rouse BT, Babiuk LA. Lymphocyte activation by cell separation procedures Immunological Communications. 5: 637-648. PMID 186400  0.231
1974 Rouse BT, Szenberg A. Functional and morphological observations on the effect of cyclophosphamide on the immune response of the chicken Australian Journal of Experimental Biology and Medical Science. 52: 873-885. PMID 4218951  0.231
1976 Wardley RC, Rouse BT, Babiuk LA. Lymphocyte activation by cell separation procedures Immunological Investigations. 5: 637-648. DOI: 10.3109/08820137609033872  0.23
2008 Mueller SN, Rouse BT. Immune responses to viruses Clinical Immunology. 421-431. DOI: 10.1016/B978-0-323-04404-2.10027-2  0.229
1975 Roellinghoff M, Rouse BT, Wagner H. T lymphocytes dependency of the immune reaction to syngeneic murine plasma cell tumors Behring Inst.Mitt.. 48-51.  0.228
1992 Daniel SL, Leqendre AM, Brenner CA, Rouse BT, Solomon A. Feline Cytokines TNFα and IL-1β: PCR Cloning and Sequencing of cDNA Animal Biotechnology. 3: 281-297. DOI: 10.1080/10495399209525777  0.227
1998 Davis IA, Rouse BT. Effect of splenectomy on mucosal immune responses of lymphotoxin-alpha deficient mice Faseb Journal. 12.  0.223
2013 Mulik S, Bhela S, Rouse BT. Potential function of miRNAs in herpetic stromal keratitis. Investigative Ophthalmology & Visual Science. 54: 563-73. PMID 23329734 DOI: 10.1167/Iovs.12-11094  0.222
1978 Ho CK, Babiuk LA, Rouse BT. Immune effector cell activity in canines: failure to demonstrate genetic restriction in direct antiviral cytotoxicity. Infection and Immunity. 19: 18-25. DOI: 10.1128/iai.19.1.18-25.1978  0.222
2000 Davis IA, Rouse BT. Identification of select lymphocyte homing molecules and vascular addressins in lymphotoxin-alpha deficient mice Laboratory Animals. 34: 111-114. PMID 10759375  0.219
1981 Rouse BT. Role of neutrophils in antiviral immunity Advances in Experimental Medicine and Biology. 137: 263-278. PMID 6174036  0.219
2020 Varanasi SK, Kumar SV, Rouse BT. Determinants of Tissue-Specific Metabolic Adaptation of T Cells. Cell Metabolism. PMID 33181092 DOI: 10.1016/j.cmet.2020.10.013  0.218
1973 Rouse BT, Röllinghoff M, Warner NL. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response. European Journal of Immunology. 3: 218-24. PMID 4541468 DOI: 10.1002/eji.1830030408  0.217
2020 Rouse BT. Peter Doherty: Role Model and Lifelong Friend Viral Immunology. 33: 133-134. DOI: 10.1089/Vim.2020.0004  0.215
1994 Niemialtowski M, Gierynska M, Rouse BT, Malicki K. The comparative analysis of human (HSV-1) and equine (EHV-1) herpes viruses. II. Vaccines - modern approaches and perspectives of development Polish Journal of Immunology. 19: 25-41.  0.215
1983 Moore RN, Rouse BT. Enhanced responsiveness of committed macrophage precursors to macrophage-type colony-stimulating factor (CSF-1) induced in vitro by interferons α + β Journal of Immunology. 131: 2374-2378. PMID 6605386  0.208
1982 Pfizenmaier K, Hardt C, Rouse B, Röllinghoff M, Scheurich P, Wagner H. Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses Cellular Immunology. 70: 393-394. DOI: 10.1016/0008-8749(82)90380-X  0.206
1992 Zhou F, Rouse BT, Huang L. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles Journal of Immunology. 149: 1599-1604. PMID 1387144  0.204
2002 Klinman DM, Zheng M, Gierynska M, Rouse BT. DNA containing bioactive CpG motifs promote angiogenesis Drug News and Perspectives. 15: 358-363. DOI: 10.1358/dnp.2002.15.6.840034  0.201
1972 Rouse BT, Röllinghoff M, Warner NL. Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour Nature: New Biology. 238: 116-117. PMID 4505425  0.2
1970 Rouse BT, Ditchfield WJ. The response of ponies to Myxovirus influenzae A-equi 2. II. Immunoglobulin classes of antibody to the virus in serum and nasal secretions Canadian Journal of Comparative Medicine. 34: 7-12. PMID 4192439  0.2
2022 Sehrawat S, Osterrieder N, Schmid DS, Rouse BT. Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals? Microbes and Infection. 25: 105078. PMID 36435367 DOI: 10.1016/j.micinf.2022.105078  0.199
2021 Berber E, Sumbria D, Rouse BT. Could targeting immunometabolism be a way to control the burden of COVID-19 infection? Microbes and Infection. 104780. PMID 33482357 DOI: 10.1016/j.micinf.2021.104780  0.197
1993 Rouse BT. Pathogenesis of the herpesviruses Laboratory Animal Science. 43: 11-14. PMID 8384675  0.195
1987 Ho RJY, Rouse BT, Huang L. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity Journal of Biological Chemistry. 262: 13973-13978. PMID 2820987  0.193
1974 Rouse BT, Warner NL. The role of suppressor cells in avian allogeneic tolerance: implications for the pathogenesis of Marek's disease. Journal of Immunology (Baltimore, Md. : 1950). 113: 904-9. PMID 4153522  0.191
2021 Dash SP, Dipankar P, Burange PS, Rouse BT, Sarangi PP. Climate change: how it impacts the emergence, transmission, resistance and consequences of viral infections in animals and plants. Critical Reviews in Microbiology. 1-16. PMID 33570448 DOI: 10.1080/1040841X.2021.1879006  0.189
2021 Miller L, Berber E, Sumbria D, Rouse BT. Controlling the Burden of COVID-19 by Manipulating Host Metabolism. Viral Immunology. 35: 24-32. PMID 34905407 DOI: 10.1089/vim.2021.0150  0.189
1976 Babiuk LA, Rouse BT. Ribonucleotides in infectious bovine rhinotracheitis virus DNA Journal of General Virology. 31: 221-230. PMID 180241  0.188
1972 Rouse BT, Wagner H, Harris AW. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes Journal of Immunology. 108: 1353-1361. PMID 4623947  0.188
1982 Rouse BT. Liposomes as carriers of antigens as well as other molecules involved in immunity Journal of the American Veterinary Medical Association. 181: 988-991. PMID 6757219  0.177
2023 Altman JD, Rouse BT. The Long-Awaited Respiratory Syncytial Virus Vaccine. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 43: 285-286. PMID 37463460 DOI: 10.1089/jir.2023.0076  0.171
1972 Rouse BT, Warner NL. Suppression of graft versus host reactions in chickens by pretreatment of leucocytes with anti-light chain sera Cellular Immunology. 3: 470-477. PMID 4401192 DOI: 10.1016/0008-8749(72)90252-3  0.17
2021 Gupta S, Rouse BT, Sarangi PP. Did Climate Change Influence the Emergence, Transmission, and Expression of the COVID-19 Pandemic? Frontiers in Medicine. 8: 769208. PMID 34957147 DOI: 10.3389/fmed.2021.769208  0.169
1970 Rouse BT, Ditchfield WJ. The response of ponies to Myxovirus influenzae A-Equi-2. 3. The protective effect of serum and nasal antibody against experimental challenge Research in Veterinary Science. 11: 503-507. PMID 5498567  0.169
1977 Babiuk LA, Acres SD, Rouse BT. Solid phase radioimmunoassay for detecting bovine (neonatal calf diarrhea) rotavirus antibody Journal of Clinical Microbiology. 6: 10-15. PMID 195982  0.168
1994 Lathey JL, Kanangat S, Rouse BT. Differential expression of tumor necrosis factor a and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction Journal of Acquired Immune Deficiency Syndromes. 7: 109-115. PMID 8301523  0.166
2000 Rouse BT, Doherty PC. IN MEMORIAM—SANGJUN CHUN Viral Immunology. 13: 2-2. DOI: 10.1089/Vim.2000.13.2  0.165
1980 Potgieter LN, Rouse BT, Webb-Martin TA. Enzyme-linked immunosorbent assay, using staphylococcal protein A for detecting virus antibodies American Journal of Veterinary Research. 41: 978-980. PMID 6776853  0.165
2017 Manickan E, Karem KL, Rouse BT. DNA Vaccines - A Modern Gimmick or a Boon to Vaccinology? Critical Reviews in Immunology. 37: 483-498. PMID 29773031 DOI: 10.1615/CritRevImmunol.v37.i2-6.140  0.164
2012 Mueller SN, Rouse BT. Host defenses to viruses Clinical Immunology: Principles and Practice: Fourth Edition. 346-355. DOI: 10.1016/B978-0-7234-3691-1.00017-9  0.161
1988 Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes Journal of Cell Biology. 107: 1853-1862. PMID 2460470 DOI: 10.1083/jcb.107.5.1853  0.161
2010 Sarangi PP, Rouse BT. Herpetic keratitis Ocular Disease: Mechanisms and Management. 91-97. DOI: 10.1016/B978-0-7020-2983-7.00012-7  0.15
1972 Rouse BT, Wagner H. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity Journal of Immunology. 109: 1282-1289. PMID 4404454  0.143
1972 Bankhurst AD, Rouse BT, Warner NL. Surface immunoglobulins on bursa-derived chicken lymphoid cells. International Archives of Allergy and Applied Immunology. 42: 187-95. PMID 4401645 DOI: 10.1159/000230605  0.142
1971 Rouse BT. Equine influenza immunisation--the role of nasal antibody--a review Australian Veterinary Journal. 47: 146-148. PMID 4931390  0.138
1970 Rouse BT, Ditchfield WJ. The response of ponies to Myxovirus influenzae A-equi 2. I. Serum and nasal antibody titres following exposure Canadian Journal of Comparative Medicine. 34: 1-5. PMID 4245998  0.132
1974 Johnson GR, Wobeser G, Rouse BT. Indirect Fluorescent Antibody Technique for Detection of RM Bacterium of Rainbow Trout (Salmo gairdneri) Journal of the Fisheries Research Board of Canada. 31: 1957-1959. DOI: 10.1139/f74-258  0.128
1973 Byrd WJ, von Boehmer H, Rouse BT. The role of the thymus in maturational development of phytohemagglutinin and pokeweed mitogen responsiveness Cellular Immunology. 6: 12-24. PMID 4539717 DOI: 10.1016/0008-8749(73)90002-6  0.128
1970 Lang G, Narayan O, Rouse BT. Prevention of malignant avian influenza by 1-adamantanamine hydrochloride. Archiv Fã¼R Die Gesamte Virusforschung. 32: 171-84. PMID 5501757 DOI: 10.1007/BF01249953  0.125
1978 Clark EG, Turner AS, Boysen BG, Rouse BT. Listeriosis in an Arabian foal with combined immunodeficiency Journal of the American Veterinary Medical Association. 172: 363-366. PMID 413818  0.124
1984 Pitruzzello FJ, Rouse BT, Moore RN. Feedback inhibition of colony-stimulating factor-induced macrophage proliferation by endogenously produced E prostaglandins and interferon α/β Federation Proceedings. 43.  0.119
2012 Cursiefen C, Colin J, Dana R, Diaz-Llopis M, Faraj LA, Garcia-Delpech S, Geerling G, Price FW, Remeijer L, Rouse BT, Seitz B, Udaondo P, Meller D, Dua H. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. The British Journal of Ophthalmology. 96: 3-9. PMID 21712359 DOI: 10.1136/Bjo.2011.204701  0.115
2023 Sayin Kocakap DB, Kaygusuz S, Aksoy E, Şahin Ö, Baççioğlu A, Ekici A, Kalpaklioğlu AF, Ekici MS, Gül S, Kaçmaz B, Ayaşlioğlu Açikgöz E, Alyilmaz Bekmez S, Rouse BT, Kürşat Azkur A. Adverse effect of VEGFR-2 (rs1870377) polymorphism on the clinical course of COVID-19 in females and males in an age-dependent manner. Microbes and Infection. 105188. PMID 37499788 DOI: 10.1016/j.micinf.2023.105188  0.076
1975 Rouse BT, Lewis RJ. Canine glomerulonephritis: prevalence in dogs submitted at random for euthanasia Canadian Journal of Comparative Medicine. 39: 365-370. PMID 1175073  0.055
1972 Rouse BT, Warner NL. Depression of humoral antibody formation in the chicken by thymectomy and antilymphocyte serum Nature: New Biology. 236: 79-80. PMID 4502459  0.052
1971 Rouse BT. The immunoglobulins of adult equine and foal sera: a quantitative study British Veterinary Journal. 127: 45-52. PMID 5541943  0.042
1967 Rouse BT, Osborne AD, Grunsell CS, Hooper RB. Acute granulocytic leukaemia in a bitch Veterinary Record. 80: 408-410. PMID 6068390  0.042
1970 Rouse BT, Angulo AB. A method for the collection of nasal secretions from the horse and cow Research in Veterinary Science. 11: 98-99. PMID 5503927  0.041
2006 Ahmed R, Rouse BT. Immunological memory Immunological Reviews. 211: 5-7. DOI: 10.1111/j.0105-2896.2006.00424.x  0.041
1970 Rouse BT, Ingram DG. The total protein and immunoglobulin profile of equine colostrum and milk Immunology. 19: 901-907. PMID 4992198  0.034
1966 Rouse BT, Wilson MR. A case of hypoglycaemia in a dog associated with neoplasia of the pancreas Veterinary Record. 79: 454-456. PMID 6008408  0.028
1973 Rouse BT. Neoplasia. What are the prospects of immunological intervention? Canadian Veterinary Journal. 14: 201-205. PMID 4585428  0.024
1976 Rouse BT. Letter: Expansion of veterinary education in Canada Canadian Veterinary Journal. 17: 30-31. PMID 1260640  0.01
Hide low-probability matches.